peptide works FAQ

Structure the experiment as parallel groups with a single endpoint timeline that allows both mechanisms to fully manifest. Minimum 21 days. Use a model with both oxidative stress and metabolic dysfunction components, such as high-fat-diet-induced insulin resistance or streptozotocin-induced diabetic cardiomyopathy. Measure acute mitochondrial function (SS-31's target), mitochondrial density and biogenesis markers (SS-LUP-332's target), and integrated whole-organism outcomes (exercise capacity, insulin sensitivity, cardiac output). Expect divergent profiles: SS-31 may show better preservation of existing mitochondrial function under stress tests, while SS-LUP-332 shows higher mitochondrial content and oxidative gene expression. The 'better' peptide depends on which outcome the research question prioritises.

No clinical evidence suggests DSIP produces tolerance, receptor downregulation, or adverse effects with extended use beyond 12 weeks. The longest published administration protocol we've reviewed ran 16 weeks without dose escalation or efficacy loss. That said, DSIP addresses the symptom (disrupted sleep) and one major cause (HPA axis dysfunction) but does not necessarily resolve underlying stressors, circadian misalignment, or sleep hygiene failures. Long-term administration should run parallel to lifestyle interventions targeting root causes. Not as a permanent replacement for addressing them.

SS-LUP-332 is the mechanistically appropriate choice. Sarcopenia involves reduced mitochondrial density, decreased oxidative enzyme activity, and fibre-type shifts toward glycolytic metabolism. All targets of ERRγ activation. Studies using SS-LUP-332 in aged rodents showed 32% increases in grip strength and 28% increases in rotarod performance after 21 days, associated with increased type IIA fibres and mitochondrial content. SS-31 wouldn't address the underlying mitochondrial deficit in the absence of acute oxidative injury. Pair SS-LUP-332 with resistance exercise protocols to determine whether the peptide enhances training adaptations or produces effects independent of mechanical stimulus.